EMVision Medical Devices Ltd (ASX:EMV)
1.570
-0.030 (-1.88%)
Apr 7, 2026, 4:11 PM AEST
EMVision Medical Devices Market Cap
EMVision Medical Devices has a market cap or net worth of 145.91 million as of April 7, 2026. Its market cap has decreased by -9.72% in one year.
Market Cap
145.91M
Enterprise Value
131.85M
Revenue
5.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.57
Market Cap Chart
Since December 13, 2018, EMVision Medical Devices's market cap has increased from 17.56M to 145.91M, an increase of 730.87%. That is a compound annual growth rate of 33.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 148.70M | -10.11% |
| Dec 31, 2025 | 165.43M | 2.08% |
| Dec 31, 2024 | 162.05M | 22.64% |
| Dec 29, 2023 | 132.14M | -8.06% |
| Dec 30, 2022 | 143.72M | -30.65% |
| Dec 31, 2021 | 207.25M | -6.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyNovo | 645.94M |
| Aroa Biosurgery | 200.38M |
| Lumos Diagnostics Holdings | 167.52M |
| Epiminder | 133.60M |
| SomnoMed | 129.26M |
| Cleo Diagnostics | 75.96M |
| Compumedics | 54.93M |
| HeraMED | 52.47M |